On December 23, 2025, Advanced Biomed Inc. sold its wholly owned Hong Kong subsidiary for $23,000, transferring all related intellectual property to the buyer, Wei Ha Hui. This transaction was unanimously approved by the company's board of directors and announced via a press release on December 30, 2025.